FSHR is expressed in up to 50% of high grade serous ovarian cancer (HGSOC) [14], however, limited studies have investigated the functional role of FSHR expression in ovarian cancer progression. This evidence concerns the gene FSHR and ovarian serous adenocarcinoma.